4//SEC Filing
JACOBSON PAUL F 4
Accession 0001209191-23-053091
CIK 0001844280other
Filed
Oct 17, 8:00 PM ET
Accepted
Oct 18, 4:57 PM ET
Size
23.2 KB
Accession
0001209191-23-053091
Insider Transaction Report
Form 4
JACOBSON PAUL F
DirectorChief Executive Officer10% Owner
Transactions
- Disposition to Issuer
Common Stock
2023-10-16−2,105,589→ 0 total - Disposition to Issuer
Employee Stock Option (Right to buy)
2023-10-16−244,750→ 0 totalExercise: $4.49Exp: 2025-02-12→ Common Stock (244,750 underlying) - Disposition to Issuer
Employee Stock Option (Right to buy)
2023-10-16−208,100→ 0 totalExercise: $1.35Exp: 2025-02-12→ Common Stock (208,100 underlying) - Disposition to Issuer
Common Stock
2023-10-16−220,377→ 0 total(indirect: See Footnote) - Disposition to Issuer
Common Stock
2023-10-16−1,602,445→ 0 total(indirect: See Footnote) - Disposition to Issuer
Employee Stock Option (Right to buy)
2023-10-16−36,045→ 0 totalExercise: $14.46Exp: 2025-10-25→ Common Stock (36,045 underlying) - Disposition to Issuer
Warrant (Right to buy)
2023-10-16−2,532,050→ 0 total(indirect: See Footnote)Exercise: $6.74Exp: 2030-06-23→ Common Stock (2,532,050 underlying) - Disposition to Issuer
Employee Stock Option (Right to buy)
2023-10-16−244,750→ 0 totalExercise: $6.74Exp: 2025-02-12→ Common Stock (244,750 underlying) - Disposition to Issuer
Employee Stock Option (Right to buy)
2023-10-16−1,279,375→ 0 totalExercise: $5.12Exp: 2028-10-10→ Common Stock (1,279,375 underlying)
Footnotes (6)
- [F1]Certain of these shares are represented by previously reported restricted stock units ("RSUs"). At the effective time of the merger (the "Effective Time") contemplated by the Agreement and Plan of Merger between the Issuer, Healthspan Buyer, LLC and Healthspan Merger Sub, Inc., dated as of August 27, 2023 (the "Merger Agreement"), (i) each issued and outstanding RSU was cancelled and converted into the right to receive an amount equal to $10.20 in cash (the "Per Share Price"), subject to the terms set forth in the Merger Agreement, and (ii) each issued and outstanding share of the Issuer's Common Stock was cancelled and converted into the right to receive an amount in cash equal to the Per Share Price.
- [F2]Pursuant to the Merger Agreement, at the Effective Time each issued and outstanding share of the Issuer's Common Stock was cancelled and converted into the right to receive an amount in cash equal to the Per Share Price.
- [F3]These shares are held by a family trust, of which the Reporting Person serves as trustee.
- [F4]These securities are held by Diversified Natural Products, Inc., over which the Reporting Person has voting and dispositive power.
- [F5]At the Effective Time, the option was cancelled pursuant to the Merger Agreement in exchange for a cash payment equal to (x) the difference between the Per Share Price and the per share exercise price of the option, multiplied by (y) the number of disposed option shares.
- [F6]At the Effective Time, the warrant was cancelled pursuant to the Merger Agreement in exchange for a cash payment equal to (x) the difference between the Per Share Price and the per share exercise price of the warrant, multiplied by (y) the number of disposed warrant shares.
Documents
Issuer
Thorne Healthtech, Inc.
CIK 0001844280
Entity typeother
Related Parties
1- filerCIK 0001250277
Filing Metadata
- Form type
- 4
- Filed
- Oct 17, 8:00 PM ET
- Accepted
- Oct 18, 4:57 PM ET
- Size
- 23.2 KB